Abstract:SESSION TITLE: Asthma IV SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: Human airway smooth muscle cells (HASMCs) play an important role in the pathogenesis of airway remodeling in asthma. HASMCs are involved in the inflammatory response through the release of inflammatory mediators. Human β-defensin (HBD) is a sub-family of small antimicrobial peptides, characterized by six conserved cysteines which compose a largely b-sheet structure by three intramolecular disulfides. Increasing evidence indicates that HBDs are related to pathogenesis of asthma. In this study, we investigated the effect of HBD-1, 2 and 3 on the release of pro-inflammatory cytokine IL-8 by HASMCs and explored the involving receptors. METHODS: The HASMCs were simulated with 0μM, 1μM, 5μM and 10μM of HBD-1, 2 and 3 for 24h respectively. IL-8 level in cell supernatant was analyzed by ELISA, and cell viability was evaluated by WST-1 assay. In order to explore the involving receptor in HBDs-induced IL-8 production, the cells were pre-treated with the blocking antibody of CCR2, CCR6, TLR2 and TLR4. RESULTS: HBD-2 and 3 but not HBD-1 significantly induced IL-8 production from HASMCs with a dose-dependent manner. However, 10μM of HBD-3 triggered significant cell death (Cell viability: 20.1±3.1% of control) although accompany with extremely higher IL-8 production (22.4±9.5 fold increase compared with control). The following results indicated that HBD-3-induced IL-8 production and cell death are independent. The administration of anti-oxidant reagent N-Acetylcysteine (NAC) could inhibit both IL-8 production and cell death induced by higher concentration of HBD-3. Furthermore, the blocking antibody against CCR6 could significantly inhibit IL-8 production induced by HBD-2 and 3. CONCLUSIONS: HBD-2 and 3 could highly induce IL-8 production through CCR6 from HASMCs, and higher concentration of HBD3 independently triggered IL-8 release and cell death, which are due to oxidative stress in HASMCs. CLINICAL IMPLICATIONS: HBD-2 and 3 may play important role in the pathogenesis of asthma by enhancing the release of pro-inflammatory cytokine IL-8 from HASMCs, which may open the new sight for target therapy of asthma. DISCLOSURE: The following authors have nothing to disclose: Wei-Jia Wang, Xiao-Yan Qu, Xiao-Min Dang, Dong Shang, Dan Xu, Yong-Ping Shao, Wu-Yuan Lu, Ying Chang No Product/Research Disclosure Information

Human Β-Defensin-2 and -3 Induce IL-8 Release Through CCR6 in Human Airway Smooth Muscle Cells

Human Beta-Defensin-3 Induces Il-8 Release and Apoptosis in Airway Smooth Muscle Cells

Human beta defensin 3 knockdown inhibits the proliferation and migration of airway smooth muscle cells through regulating the PI3K/AKT signaling pathway

HMGB1-induced ILC2s Activate Dendritic Cells by Producing IL-9 in Asthmatic Mouse Model.

IL-33 amplifies airways inflammation in a murine surrogate of asthma possibly through acting on dendritic cells

EphA2 recognizes Dermatophagoides pteronyssinus to mediate airway inflammation in asthma

B-cell-derived IL-10 promotes allergic sensitization in asthma regulated by Bcl-3

Annexin 1-Derived Peptide Ac2-26 Inhibits Eosinophil Recruitment in Vivo Via Decreasing Prostaglandin D2

IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk

ITGB4 Deficiency in Airway Epithelia Enhances HDM-induced Airway Inflammation Through Hyperactivation of TLR4 Signaling Pathway

IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways

IL-1β: a Key Modulator in Asthmatic Airway Smooth Muscle Hyper-Reactivity

Cadherin-26 drives macrophage alternative activation via suppressing STUB1-mediated IL-4Rα ubiquitination in asthma

Antigen Presentation Action of Human Bronchial Epithelial Cells Mediated by Bombesin Receptor Subtype 3 Activation

Bidirectional Counterregulation of Human Lung Mast Cell and Airway Smooth Muscle β2 Adrenoceptors

Extracellular Heat Shock Protein 90α Mediates HDM-induced Bronchial Epithelial Barrier Dysfunction by Activating RhoA/MLC Signaling

B7-H3 Participates in the Development of Asthma by Augmentation of the Inflammatory Response Independent of TLR2 Pathway

Bronchial Epithelial Cells Release IL-6, CXCL1 and CXCL8 Upon Mast Cell Interaction.

Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists

Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma

Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses